Debra Patt, MD, PhD, MBA, executive vice president at Texas Oncology, explains the small potential risk of breast cancer associated with hormonal birth control.
Hormonal birth control carries risks of adverse events, as do all medications, and one association appears to be a very slightly increased risk of breast cancer, according to Debra Patt, MD, PhD, MBA, executive vice president, Texas Oncology.
Transcript
Should people be concerned over the recent study gaining media attention that hormonal birth control increases risk of breast cancer?
Sure, I think that with any drug that you take, you should always be cognizant of the desired effects and unintended side effects of any medication. For patients, hormonal contraception can very slightly, and I will say very slightly, increase the risk for breast cancer. We know that's a cumulative risk.
I think for every patient, like with any therapy, you need to carefully think about the effects that are desired in contrast to the potential side effects, because it's not a universal recommendation for every patient.
For example, if you have a patient that is just desiring a mechanism of contraception, and they have a very high breast cancer risk because of a genetic susceptibility or family members who've had breast cancer, for them, the decision might be very different than someone who has no family history of breast cancer and has contraindications to other forms of contraception. So, I think it varies per patient. But yes, it's a risk. But it's a very small risk.
Actually, I think that most patients take oral contraceptives safely without any increased risk for breast cancer. The truth is—and everyone asks, because breast cancer is common—if this caused it or that caused it, but breast cancer is just common; 1 out of 8 women will get breast cancer in their lifetime. So, the percentage of that risk that you can attribute to a history of oral contraceptive use is really quite small.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More